Close Menu

NEW YORK (GenomeWeb) – Molecular Devices announced today that it has signed an agreement to help launch Cytena's CloneSelect single-cell printer in North America.

The printer uses microfluidics and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for use in cell line development. It has particular use in antibody discovery, enabling the automated isolation of single cells into standard 96- and 384-well plates for a wide range of cell types, according to Molecular Devices.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.